» Articles » PMID: 17310289

Value of Image Fusion in the Staging of Prostatic Carcinoma

Overview
Journal Radiol Med
Specialty Radiology
Date 2007 Feb 21
PMID 17310289
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: We assessed the value of image fusion in the staging of prostatic cancer in a series of 32 patients who underwent preoperative evaluation with transrectal colour-Doppler ultrasonography (TRUS) and magnetic resonance imaging (MRI).

Materials And Methods: Colour-Doppler TRUS exams were performed using a 7.5-MHz biplanar probe. MRI exams were done with a scanner operating at 1.5 Tesla (T) using an endorectal coil. All patients underwent radical prostatectomy within 2 weeks from the imaging assessment. Whole-mount sections were prepared from the surgical specimens and were subsequently digitised by using a high-resolution scanner. The Digital Imaging and Communications in Medicine (DICOM) TRUS and MR images as well as the digitised pathological images were transferred to a graphic workstation to perform image fusion.

Results: Image fusion was technically possible in 25/32 cases in which axial TRUS images were available. The following fusion images were obtained: TRUS + pathological sections; MRI + pathological sections; TRUS + MRI + pathological sections. The final pathological staging concerning the T status was: four pT2b, fourteen pT2c, three pT3a and four pT3b. The three types of image fusion led to the following results: TRUS + pathological sections, correct staging in 20/25 cases (accuracy 80%); MRI + pathological sections, correct staging in 22/25 cases (accuracy 88%); TRUS + MRI + pathological sections, correct staging in 23/25 cases (accuracy 92%).

Conclusions: Our study suggests that by using image fusion between colour-Doppler TRUS and endorectal MRI, it is possible to improve the accuracy of pathological staging in patients who are candidates for radical prostatectomy.

Citing Articles

A system for evaluating magnetic resonance imaging of prostate cancer using patient-specific 3D printed molds.

Priester A, Natarajan S, Le J, Garritano J, Radosavcev B, Grundfest W Am J Clin Exp Urol. 2014; 2(2):127-35.

PMID: 25374914 PMC: 4219304.


Impact of intraoperative MRI/TRUS fusion on dosimetric parameters in cT3a prostate cancer patients treated with high-dose-rate real-time brachytherapy.

Gomez-Iturriaga A, Crook J, Casquero F, Carvajal C, Urresola A, Canteli B J Contemp Brachytherapy. 2014; 6(2):154-60.

PMID: 25097555 PMC: 4105645. DOI: 10.5114/jcb.2014.43299.


Dimensional stability in composite cone beam computed tomography.

Kopp S, Ottl P Dentomaxillofac Radiol. 2010; 39(8):512-6.

PMID: 21062945 PMC: 3520214. DOI: 10.1259/dmfr/28358586.


Computer-assisted diagnosis of prostate cancer using DCE-MRI data: design, implementation and preliminary results.

Puech P, Betrouni N, Makni N, Dewalle A, Villers A, Lemaitre L Int J Comput Assist Radiol Surg. 2009; 4(1):1-10.

PMID: 20033597 DOI: 10.1007/s11548-008-0261-2.


MR-guided prostate interventions.

Tempany C, Straus S, Hata N, Haker S J Magn Reson Imaging. 2008; 27(2):356-67.

PMID: 18219689 PMC: 2683388. DOI: 10.1002/jmri.21259.